NASDAQ:FOLD
Amicus Therapeutics Stock News
$9.23
-0.250 (-2.64%)
At Close: May 10, 2024
Why Is Amicus Therapeutics (FOLD) Up 10.9% Since Last Earnings Report?
03:31pm, Saturday, 06'th Jun 2020
Amicus Therapeutics (FOLD) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Amicus Therapeutics, Inc. (FOLD): Hedge Funds Folding Their Hands
02:49pm, Saturday, 06'th Jun 2020
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data. We at Insider Monkey have plowed through 821 13F
What Lone Bad Apple?
01:25am, Saturday, 06'th Jun 2020
When it comes to the police, there is no such thing.
Martin Gugino, Buffalo man pushed by police, is long-time peace activist
09:52pm, Friday, 05'th Jun 2020
Martin Gugino — the 75-year-old man who was shoved to the ground by Buffalo police in a video seen by millions — is a long-time peace activist and “gentle person,” according…
Colin Farrell hails friend with rare disease as she preps for charity challenge
04:06pm, Thursday, 04'th Jun 2020
Farrell and Irish rugby captain Johnny Sexton have both sent video messages to Emma Fogarty who suffers from Epidermolysis Bullosa
Amicus Therapeutics to Present at the Goldman Sachs 41st Annual Global Healthcare Conference
11:00am, Thursday, 04'th Jun 2020
CRANBURY, N.J., June 04, 2020 -- Amicus Therapeutics (Nasdaq: FOLD) today announced that John F. Crowley, Chairman and Chief Executive Officer, will participate in a fireside.
Colin Farrell hails charity challenge by brave friend with rare...
10:50am, Thursday, 04'th Jun 2020
Emma Fogarty, who has a disorder known as butterfly skin, is trying to complete 36km to mark her 36th birthday later this month.
Colin Farrell hails charity challenge by brave friend with rare skin disease
10:49am, Thursday, 04'th Jun 2020
Emma Fogarty, who has a disorder known as butterfly skin, is trying to complete 36km to mark her 36th birthday later this month.
COVID-19 driving adoption of virtual trials -
08:42am, Thursday, 04'th Jun 2020
Survey of clinical trial professionals by ERT says use of virtual approaches has risen from 33% before the coronavirus pandemic to 82%
Protalix, Chiesi edge close to potential Fabry disease approval
12:05pm, Thursday, 28'th May 2020
Israeli biotech Protalix BioTherapeutics and partner Chiesi have sent off their Biologics License Application for rare disease hopeful pegunigalsidase alfa to the FDA.
Beating Covid-19 will change how new therapies are developed - STAT
09:00am, Wednesday, 27'th May 2020
The Covid-19 pandemic is driving an unprecedented transformation of the global medical research ecosystem through the search for new therapies and vaccines.
Edited Transcript of FOLD earnings conference call or presentation 7-May-20 12:30pm GMT
06:25pm, Thursday, 21'st May 2020
Q1 2020 Amicus Therapeutics Inc Earnings Call
Billionaire Steven Cohen Bets Big on These 3 Stocks
01:47pm, Tuesday, 19'th May 2020
And they’re off to the races. All three of the major U.S. stock indexes popped on Monday after biotech company Moderna reported its experimental COVID-19 vaccine produced encouraging results in its
AVROBIO Presents New Preclinical Data on Lentiviral Gene Therapy Program for Pompe Disease at ASGCT 2020
12:00am, Thursday, 14'th May 2020
AVROBIO, Inc. (Nasdaq: AVRO), a leading clinical-stage gene therapy company with a mission to free people from a lifetime of genetic disease, today an